Minimal residual disease diagnostics in acute lymphoblastic leukaemia: impact of primer characteristics and size of junctional regions-Reference-Cited by-同舟云学术

Minimal residual disease diagnostics in acute lymphoblastic leukaemia: impact of primer characteristics and size of junctional regions

Published:2013-10-26 Issue:3 Volume:164 Page:451-453
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

van der Velden Vincent H. J.¹,Noordijk Rianne¹,Brussee Mark²,Hoogeveen Patricia G.¹,Homburg Christa²,de Haas Valerie³,van der Schoot C. Ellen²,van Dongen Jacques J. M.¹

Affiliation:

1. Department of Immunology; Erasmus MC; University Medical Centre Rotterdam; Rotterdam The Netherlands

2. Department of Experimental immunohematology; Sanquin; Amsterdam The Netherlands

3. Dutch Childhood Oncology Group; The Hague The Netherlands

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12621/fullpdf

Reference8 articles.

1. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia;Flohr;Leukemia,2008

2. Risk-adapted therapy: lessons from childhood acute lymphoblastic leukemia;Schrappe;The Hematology Journal,2002

3. Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?;Szczepanski;Leukemia,2007

4. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR;Velden;Methods in Molecular Biology,2009

5. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis;Velden;Leukemia,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of the PCR by genomic DNA;PLOS ONE;2023-04-21

2. Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCR;The Journal of Molecular Diagnostics;2022-06

3. Expression of CD304/neuropilin‐1 in adult b‐cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment;International Journal of Laboratory Hematology;2021-01-12

4. Minimal Residual Disease Detection in Pediatric Acute Lymphoblastic Leukemia;Clinical Pediatric Hematology-Oncology;2020-10-31

5. Immunophenotypic shift in the B ‐cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B ‐lymphoblastic leukemia;Cytometry Part B: Clinical Cytometry;2020-09-08